Marshall Wace, LLP Boston Scientific Corp Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 3,112,322 shares of BSX stock, worth $240 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,112,322

Previous 1,617,301 92.44%

Holding current value

$240 Million

Previous $93.5 Million 127.99%

% of portfolio

0.34%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $86.1 Million - $103 Million	1,495,021 Added 92.44%	3,112,322 $213 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $106 Million - $126 Million	-2,185,557 Reduced 57.47%	1,617,301 $93.5 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $96.4 Million - $105 Million	1,921,591 Added 102.14%	3,802,858 $201 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $117 Million - $128 Million	-2,351,499 Reduced 55.55%	1,881,267 $102 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $71.7 Million - $79.5 Million	-1,589,247 Reduced 27.3%	4,232,766 $212 Million

Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $169 Million - $202 Million	-4,268,346 Reduced 42.3%	5,822,013 $269 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $14.3 Million - $42.6 Million	-388,778 Reduced 3.71%	10,090,359 $391 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $33.1 Million - $44.2 Million	938,755 Added 9.84%	10,479,137 $391 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $130 Million - $144 Million	3,182,702 Added 50.06%	9,540,382 $423 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $206 Million - $243 Million	5,411,822 Added 572.16%	6,357,680 $270 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.19 Million - $1.33 Million	-28,943 Reduced 2.97%	945,858 $41 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $21.8 Million - $25 Million	565,427 Added 138.12%	974,801 $41.7 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $11.5 Million - $12.9 Million	-325,708 Reduced 44.31%	409,374 $15.8 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $8.41 Million - $10.7 Million	253,798 Added 52.73%	735,082 $26.4 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $129 Million - $159 Million	-3,759,644 Reduced 88.65%	481,284 $18.4 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $15.3 Million - $19.8 Million	506,108 Added 13.55%	4,240,928 $149 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $115 Million - $203 Million	-4,436,532 Reduced 54.29%	3,734,820 $122 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $11.1 Million - $13.3 Million	-292,339 Reduced 3.45%	8,171,352 $370 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $43.6 Million - $47 Million	-1,081,691 Reduced 11.33%	8,463,691 $344 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $179 Million - $221 Million	5,131,591 Added 116.26%	9,545,382 $410 Million
Q1 2019 May 14, 2019	BUY	$32.91 - $40.75 $104 Million - $129 Million	3,158,088 Added 251.5%	4,413,791 $169 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $19.1 Million - $23.5 Million	602,875 Added 92.35%	1,255,703 $44.4 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $40.1 Million - $47.1 Million	-1,220,533 Reduced 65.15%	652,828 $25.1 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $47 Million - $60.1 Million	1,751,500 Added 1437.29%	1,873,361 $61.3 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $273,495 - $309,744	10,853 Added 9.78%	121,861 $3.33 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $744,989 - $895,549	30,052 Added 37.12%	111,008 $2.75 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $2.13 Million - $2.36 Million	80,956	80,956 $2.35 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $110B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Boston Scientific Corp Transaction History